{
  "drugs": [
    {
      "id": "levodopa",
      "name": "Levodopa",
      "module": "pd",

      "therapeutic_area": "Parkinson’s Disease",
      "mechanism_of_action": "Dopamine precursor converted in CNS",
      "target": "DOPA decarboxylase pathway",

      "pharmacophore": [
        "Catechol ring",
        "Primary amine",
        "Amino acid backbone"
      ],

      "sar": [
        "Catechol is essential for receptor binding",
        "Peripheral metabolism limits bioavailability",
        "Carbidopa improves CNS delivery"
      ],

      "metabolism": "Decarboxylation + COMT methylation",
      "pk_admet": "Short half-life; BBB penetration via transporter",
      "ddis": [
        "High-protein meals reduce absorption",
        "Nonselective MAO inhibitors contraindicated"
      ],

      "clinical_significance": "Most effective agent for motor symptoms",

      "checkpoints": [
        {
          "question": "Which functional group is required for dopamine receptor activity?",
          "options": ["Random alkyl chain", "Catechol ring", "Ester only"],
          "answer": "Catechol ring",
          "hint": "Think aromatic hydroxyl binding interactions."
        }
      ]
    },

    {
      "id": "carbamazepine",
      "name": "Carbamazepine",
      "module": "aed",

      "therapeutic_area": "Epilepsy (Focal Seizures)",
      "mechanism_of_action": "Use-dependent Na⁺ channel blocker",
      "target": "Voltage-gated sodium channels",

      "pharmacophore": [
        "Tricyclic scaffold",
        "Carboxamide group"
      ],

      "sar": [
        "Tricyclic core mimics TCA-like binding",
        "Epoxide metabolite contributes to toxicity"
      ],

      "metabolism": "CYP3A4 → active epoxide; autoinduction",
      "pk_admet": "Lipophilic; strong hepatic enzyme inducer",
      "ddis": [
        "Induces CYP enzymes (↓ warfarin, OCs)",
        "Interactions with other antiseizure meds"
      ],

      "clinical_significance": "Effective but requires monitoring",

      "checkpoints": [
        {
          "question": "Carbamazepine is best classified as:",
          "options": ["GABA agonist", "Na⁺ channel blocker", "NMDA antagonist"],
          "answer": "Na⁺ channel blocker",
          "hint": "Think use-dependent inactivation."
        }
      ]
    }
  ]
}
